ENDRA Life Sciences Statistics
Total Valuation
NDRA has a market cap or net worth of $2.81 million. The enterprise value is $367,978.
| Market Cap | 2.81M |
| Enterprise Value | 367,978 |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, after market close.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NDRA has 11.04 million shares outstanding. The number of shares has increased by 120.10% in one year.
| Shares Outstanding | 11.04M |
| Shares Change (YoY) | +120.10% |
| Shares Change (QoQ) | -17.18% |
| Owned by Insiders (%) | 3.15% |
| Owned by Institutions (%) | 1.18% |
| Float | 10.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 2.75 |
| PB Ratio | 0.50 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.36, with a Debt / Equity ratio of 0.07.
| Current Ratio | 3.36 |
| Quick Ratio | n/a |
| Debt / Equity | 0.07 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -180.60% and return on invested capital (ROIC) is -173.80%.
| Return on Equity (ROE) | -180.60% |
| Return on Assets (ROA) | -133.00% |
| Return on Capital (ROIC) | -173.80% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$479,060 |
| Employee Count | 21 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.09% in the last 52 weeks. The beta is 1.00, so NDRA's price volatility has been similar to the market average.
| Beta (1Y) | 1.00 |
| 52-Week Price Change | -87.09% |
| 50-Day Moving Average | 0.81 |
| 200-Day Moving Average | 1.10 |
| Relative Strength Index (RSI) | 21.95 |
| Average Volume (30 Days) | 175,085 |
Short Selling Information
The latest short interest is 30,608, so 0.28% of the outstanding shares have been sold short.
| Short Interest | 30,608 |
| Short Previous Month | 48,453 |
| Short % of Shares Out | 0.28% |
| Short % of Float | 0.29% |
| Short Ratio (days to cover) | 0.13 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -10.52M |
| Pretax Income | -10.06M |
| Net Income | -10.06M |
| EBITDA | -9.78M |
| EBIT | -10.06M |
| Earnings Per Share (EPS) | -$1.58 |
Balance Sheet
The company has $2.83 million in cash and $394,403 in debt, giving a net cash position of $2.44 million or $0.22 per share.
| Cash & Cash Equivalents | 2.83M |
| Total Debt | 394,403 |
| Net Cash | 2.44M |
| Net Cash Per Share | $0.22 |
| Equity / Book Value | 5.66M |
| Book Value Per Share | 0.51 |
| Working Capital | 2.13M |
Cash Flow
In the last 12 months, operating cash flow was -$9.55 million and capital expenditures -$24,721, giving a free cash flow of -$9.57 million.
| Operating Cash Flow | -9.55M |
| Capital Expenditures | -24,721 |
| Free Cash Flow | -9.57M |
| FCF Per Share | -$1.50 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NDRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -120.10% |
| Shareholder Yield | -120.10% |
| Earnings Yield | -358.34% |
| FCF Yield | -341.00% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 9, 2022. It was a reverse split with a ratio of 1:20.
| Last Split Date | Dec 9, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |